Msci Inc (NYSE:MSCI) Shares Sold by Metropolitan Life Insurance Co. NY

Metropolitan Life Insurance Co. NY trimmed its position in shares of Msci Inc (NYSE:MSCI) by 1.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,084 shares of the technology company’s stock after selling 172 shares during the period. Metropolitan Life Insurance Co. NY’s holdings in Msci were worth $2,519,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in MSCI. Franklin Resources Inc. increased its holdings in Msci by 43.3% in the third quarter. Franklin Resources Inc. now owns 1,265,588 shares of the technology company’s stock valued at $224,540,000 after buying an additional 382,115 shares during the last quarter. Carillon Tower Advisers Inc. purchased a new position in shares of Msci during the third quarter worth about $47,395,000. DSM Capital Partners LLC grew its holdings in shares of Msci by 24.6% during the fourth quarter. DSM Capital Partners LLC now owns 1,252,070 shares of the technology company’s stock worth $184,593,000 after purchasing an additional 247,304 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Msci by 34.2% during the third quarter. Bank of New York Mellon Corp now owns 926,585 shares of the technology company’s stock worth $164,385,000 after purchasing an additional 235,998 shares during the last quarter. Finally, Marshall Wace LLP grew its holdings in shares of Msci by 74.4% during the third quarter. Marshall Wace LLP now owns 525,781 shares of the technology company’s stock worth $93,279,000 after purchasing an additional 224,301 shares during the last quarter. Institutional investors own 93.54% of the company’s stock.

Several brokerages have issued reports on MSCI. Zacks Investment Research raised Msci from a “hold” rating to a “buy” rating and set a $207.00 price objective on the stock in a report on Wednesday, March 13th. BMO Capital Markets set a $190.00 price objective on Msci and gave the stock a “buy” rating in a report on Saturday, February 2nd. UBS Group increased their target price on shares of Msci to $234.00 and gave the stock a “buy” rating in a research note on Monday, April 8th. Morgan Stanley decreased their target price on shares of Msci from $172.00 to $159.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 8th. Finally, Buckingham Research assumed coverage on shares of Msci in a research report on Friday, January 25th. They issued a “neutral” rating and a $171.00 price objective for the company. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $190.78.

Msci stock traded up $1.00 during mid-day trading on Monday, reaching $218.99. The company had a trading volume of 477,000 shares, compared to its average volume of 622,011. Msci Inc has a 1 year low of $134.28 and a 1 year high of $219.47. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 6.80. The stock has a market cap of $18.55 billion, a PE ratio of 40.93, a price-to-earnings-growth ratio of 3.51 and a beta of 1.16.

Msci (NYSE:MSCI) last issued its earnings results on Thursday, January 31st. The technology company reported $1.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.01. Msci had a net margin of 35.42% and a return on equity of 196.12%. The company had revenue of $361.69 million during the quarter, compared to analysts’ expectations of $360.95 million. On average, sell-side analysts forecast that Msci Inc will post 6.15 EPS for the current fiscal year.

In other Msci news, insider Scott A. Crum sold 19,000 shares of Msci stock in a transaction that occurred on Friday, February 15th. The shares were sold at an average price of $175.14, for a total value of $3,327,660.00. Following the completion of the sale, the insider now directly owns 96,999 shares of the company’s stock, valued at approximately $16,988,404.86. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 3.10% of the company’s stock.

WARNING: “Msci Inc (NYSE:MSCI) Shares Sold by Metropolitan Life Insurance Co. NY” was posted by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright laws. The correct version of this article can be read at https://www.baseballdailydigest.com/news/2019/04/15/msci-inc-msci-stake-lessened-by-metropolitan-life-insurance-co-ny.html.

About Msci

MSCI Inc, together with its subsidiaries, provides investment decision support tools for the clients to manage their investment processes worldwide. The company operates through four segments: Index, Analytics, ESG, and Real Estate. The Index segment primarily provides equity indexes for use in various areas of the investment process, including index-linked product creation and performance benchmarking, as well as portfolio construction and rebalancing, and asset allocation.

See Also: Is it Safe to Invest in Commodities?

Institutional Ownership by Quarter for Msci (NYSE:MSCI)

Receive News & Ratings for Msci Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Msci and related companies with MarketBeat.com's FREE daily email newsletter.